Saxagliptin

Details

Files

Generic Name:

Saxagliptin

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus (Type 2)

Manufacturer:

Bristol-Myers Squibb Canada

Brand Name:

Onglyza

Project Line:

Reimbursement Review

Project Number:

SR0185-000

Submission Type:

Initial

Indications:

Diabetes mellitus (Type 2)

Recommendation Type:

Do not list

Final Recommendation:

June 17, 2010

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : November 9, 2009